BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18555540)

  • 21. Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.
    Dressel A; Kolb AK; Elitok E; Bitsch A; Bogumil T; Kitze B; Tumani H; Weber F
    Acta Neurol Scand; 2006 Dec; 114(6):368-73. PubMed ID: 17083335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Scand J Immunol; 2005 Aug; 62(2):176-82. PubMed ID: 16101825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis.
    Liguori M; Fera F; Gioia MC; Valentino P; Manna I; Condino F; Cerasa A; La Russa A; Clodomiro A; Paolillo A; Nisticò R; Vercillo L; Cittadella R; Quattrone A
    Genes Brain Behav; 2007 Mar; 6(2):177-83. PubMed ID: 16740142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
    Azoulay D; Urshansky N; Karni A
    J Neuroimmunol; 2008 Mar; 195(1-2):186-93. PubMed ID: 18329726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon inhibitory activity in patients with multiple sclerosis.
    Chadha K; Weinstock-Guttman B; Zivadinov R; Bhasi K; Muhitch J; Feichter J; Tamaño-Blanco M; Abdelrahman N; Ambrus J; Munschauer F; Ramanathan M
    Arch Neurol; 2006 Nov; 63(11):1579-84. PubMed ID: 17101826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis.
    Cosentino M; Zaffaroni M; Ferrari M; Marino F; Bombelli R; Rasini E; Frigo G; Ghezzi A; Comi G; Lecchini S
    J Neuroimmunol; 2005 May; 162(1-2):112-21. PubMed ID: 15833366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IFN-beta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactions.
    Yamaguchi KD; Ruderman DL; Croze E; Wagner TC; Velichko S; Reder AT; Salamon H
    J Neuroimmunol; 2008 Mar; 195(1-2):116-20. PubMed ID: 18279974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate.
    Azoulay D; Vachapova V; Shihman B; Miler A; Karni A
    J Neuroimmunol; 2005 Oct; 167(1-2):215-8. PubMed ID: 16083971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis.
    Hong J; Zang YC; Hutton G; Rivera VM; Zhang JZ
    J Neuroimmunol; 2004 Jul; 152(1-2):126-39. PubMed ID: 15223245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients.
    Weinstock-Guttman B; Bhasi K; Badgett D; Tamaño-Blanco M; Minhas M; Feichter J; Patrick K; Munschauer F; Bakshi R; Ramanathan M
    J Neuroimmunol; 2008 Dec; 205(1-2):113-25. PubMed ID: 18950872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression analysis of interferon-beta treatment in multiple sclerosis.
    Sellebjerg F; Datta P; Larsen J; Rieneck K; Alsing I; Oturai A; Svejgaard A; Soelberg Sørensen P; Ryder LP
    Mult Scler; 2008 Jun; 14(5):615-21. PubMed ID: 18408020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects.
    Raap U; Goltz C; Deneka N; Bruder M; Renz H; Kapp A; Wedi B
    J Allergy Clin Immunol; 2005 Jun; 115(6):1268-75. PubMed ID: 15940146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs.
    Karege F; Vaudan G; Schwald M; Perroud N; La Harpe R
    Brain Res Mol Brain Res; 2005 May; 136(1-2):29-37. PubMed ID: 15893584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-beta: mechanism of action and dosing issues.
    Markowitz CE
    Neurology; 2007 Jun; 68(24 Suppl 4):S8-11. PubMed ID: 17562848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis.
    Angelucci F; Mirabella M; Caggiula M; Frisullo G; Patanella K; Sancricca C; Nociti V; Tonali PA; Batocchi AP
    Peptides; 2005 Nov; 26(11):2289-93. PubMed ID: 16269354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis.
    Yoshimura S; Ochi H; Isobe N; Matsushita T; Motomura K; Matsuoka T; Minohara M; Kira J
    Mult Scler; 2010 Oct; 16(10):1178-88. PubMed ID: 20656764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon beta-1a induces tumor necrosis factor receptor 1 but decreases tumor necrosis factor receptor 2 leukocyte mRNA levels in relapsing-remitting multiple sclerosis.
    Reuss R; Pohle S; Retzlaff K; Hemberger J; Oschmann P
    Neuroimmunomodulation; 2009; 16(3):171-6. PubMed ID: 19246939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.
    Desai F; Ramanathan M; Fink CS; Wilding GE; Weinstock-Guttman B; Awad AB
    Int Immunopharmacol; 2009 Jan; 9(1):153-7. PubMed ID: 19022404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
    Biernacki K; Antel JP; Blain M; Narayanan S; Arnold DL; Prat A
    Arch Neurol; 2005 Apr; 62(4):563-8. PubMed ID: 15824253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of multiple sclerosis patients with interferon-beta primes monocyte-derived macrophages for apoptotic cell death.
    Van Weyenbergh J; Wietzerbin J; Rouillard D; Barral-Netto M; Liblau R
    J Leukoc Biol; 2001 Nov; 70(5):745-8. PubMed ID: 11698494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.